Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Neuronal Ceroid Lipofuscinosis 14 via the KCTD7 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Early Infantile Epileptic Encephalopathy Panel PreventionGenetics, part of Exact Sciences United States | 144 | 124 |
|
Neuronal Ceroid Lipofuscinoses (Batten Disease) Panel PreventionGenetics, part of Exact Sciences United States | 15 | 13 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 414 | 800 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Comprehensive Epilepsy Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 234 | 240 |
|
Epilepsy, progressive myoclonic 3 (sequence analysis of KCTD7 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Neuronal ceroid lipofuscinosis and progressive myoclonic epilepsy panel. 31-gene NGS panel. Genologica Medica Spain | 46 | 31 |
|
Nöronal Ceroid Lipofuscinosis (NCL) Genetic Panel Duzen Laboratories Duzen BBAGUAS Turkey | 16 | 15 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 132 | 83 |
|
Epilepsy, progressive myoclonic: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 11 | 11 |
|
Fulgent Genetics United States | 509 | 275 |
|
Progressive Myoclonic Epilepsy NGS Panel Fulgent Genetics United States | 36 | 17 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Storage and Energetic Metabolism Diseases , Panel Massive Sequencing (NGS) 82 genes Reference Laboratory Genetics Spain | 108 | 82 |
|
Neuronal Ceroid Lipofuscinoses , Panel Massive Sequencing (NGS) 11 Genes Reference Laboratory Genetics Spain | 13 | 11 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 233 | 234 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Neuronal Ceroid Lipofuscinosis Athena Diagnostics United States | 13 | 13 |
|
Athena Diagnostics United States | 80 | 84 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.